Literature DB >> 19782129

The dopamine D4 receptor activates intracellular platelet-derived growth factor receptor beta to stimulate ERK1/2.

Robin S Gill1, Marilyn S Hsiung, Chi S Sum, Natalie Lavine, Stewart D Clark, Hubert H M Van Tol.   

Abstract

Dopamine receptors are GPCRs that play important roles in locomotion, reward, and cognitive processes. Previously, we demonstrated that this receptor transactivates PDGFRbeta to modulate ERK1/2 and NMDA receptor activity. Downregulation of maturely glycosylated PDGFRbeta by prolonged exposure to PDGF-BB eliminated PDGF-BB-mediated ERK1/2 activation. The DRD4-mediated ERK1/2 response was only partially blunted by PDGF-BB-mediated downregulation, but remained sensitive to the PDGFRbeta kinase inhibitor tyrphostin A9. Tunicamycin prevented the N-linked glycosylation and maturation of PDGFRbeta as well as its activation by PDGF-BB. However, upon tunicamycin treatment, DRD4 continued to signal to ERK1/2 in a tyrphostin A9-sensitive manner. Collectively, our observations indicate that DRD4, unlike PDGF-BB, can activate a pool of intracellularly located PDGFRbeta.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19782129     DOI: 10.1016/j.cellsig.2009.09.031

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  9 in total

Review 1.  Novel dopamine D2 receptor signaling through proteins interacting with the third cytoplasmic loop.

Authors:  Kohji Fukunaga; Norifumi Shioda
Journal:  Mol Neurobiol       Date:  2011-12-20       Impact factor: 5.590

Review 2.  The dopamine D4 receptor: biochemical and signalling properties.

Authors:  Pieter Rondou; Guy Haegeman; Kathleen Van Craenenbroeck
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

3.  Interactions between cadherin-11 and platelet-derived growth factor receptor-alpha signaling link cell adhesion and proliferation.

Authors:  Bhanupriya Madarampalli; Gerald F M Watts; Paul M Panipinto; Hung N Nguygen; Michael B Brenner; Erika H Noss
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-03-13       Impact factor: 5.187

4.  Cross-talk between lysophosphatidic acid receptor 1 and tropomyosin receptor kinase A promotes lung epithelial cell migration.

Authors:  Ling Nan; Jianxin Wei; Anastasia M Jacko; Miranda K Culley; Jing Zhao; Viswanathan Natarajan; Haichun Ma; Yutong Zhao
Journal:  Biochim Biophys Acta       Date:  2015-11-17

5.  Inhibition of Dopamine Receptor D4 Impedes Autophagic Flux, Proliferation, and Survival of Glioblastoma Stem Cells.

Authors:  Sonam Dolma; Hayden J Selvadurai; Xiaoyang Lan; Lilian Lee; Michelle Kushida; Veronique Voisin; Heather Whetstone; Milly So; Tzvi Aviv; Nicole Park; Xueming Zhu; ChangJiang Xu; Renee Head; Katherine J Rowland; Mark Bernstein; Ian D Clarke; Gary Bader; Lea Harrington; John H Brumell; Mike Tyers; Peter B Dirks
Journal:  Cancer Cell       Date:  2016-06-13       Impact factor: 31.743

6.  Transactivation of PDGFRbeta by dopamine D4 receptor does not require PDGFRbeta dimerization.

Authors:  Sum Shing Chi; Sandra M Vetiska; Robin S Gill; Marilyn S Hsiung; Fang Liu; Hubert Hm Van Tol
Journal:  Mol Brain       Date:  2010-07-26       Impact factor: 4.041

7.  Silibinin Inhibits Platelet-Derived Growth Factor-Driven Cell Proliferation via Downregulation of N-Glycosylation in Human Tenon's Fibroblasts in a Proteasome-Dependent Manner.

Authors:  Yi-Hao Chen; Ching-Long Chen; Da-Wen Lu; Chang-Min Liang; Ming-Cheng Tai; Jiann-Torng Chen
Journal:  PLoS One       Date:  2016-12-28       Impact factor: 3.240

8.  Epigenetic repression of the dopamine receptor D4 in pediatric tumors of the central nervous system.

Authors:  Rebekka Unland; Kornelius Kerl; Sabrina Schlosser; Nicole Farwick; Tanja Plagemann; Birigit Lechtape; Steven C Clifford; Jonas H Kreth; Joachim Gerss; Jörg Mühlisch; Günther H S Richter; Martin Hasselblatt; Michael C Frühwald
Journal:  J Neurooncol       Date:  2013-11-22       Impact factor: 4.130

9.  Reactive oxygen species are required for 5-HT-induced transactivation of neuronal platelet-derived growth factor and TrkB receptors, but not for ERK1/2 activation.

Authors:  Jeff S Kruk; Maryam S Vasefi; John J Heikkila; Michael A Beazely
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.